Results for "antihypertensive factor"
- AHF: antihypertensive factor
- AH: antihypertensive
- AHT: antihypertensive
- CA: Classes of antihypertensive
- AHD: antihypertensive drugs
- AHM: antihypertensive medication
- AHT: antihypertensive therapy
- AHT: antihypertensive treatment
- CA: Compliance with antihypertensive
- ATRD: Antihypertensive Treatment of Renal Disease
- PEAR: Pharmacogenomic Evaluation of Antihypertensive Response
- TAIM: Trial of Antihypertensive Interventions & Management
- TAIM: Trial of Antihypertensive Intervention Management
- APIS: Antihypertensive Patch Italian Study
- ALL: Antihypertensive and Lipid Lowering
- WAP: withdrawal-induced antihypertensive phenomenon
- APRL: Antihypertensive Polar Renomedullary Lipid
- ALL: Antihypertensive and Lipid-Lowering
- ANRL: antihypertensive neutral renomedullary lipid
- PEAR: Pharmacogenomic Evaluation of Antihypertensive Responses
- PATS: Poststroke Antihypertensive Treatment Study
- APIS: Antihypertensive Patch, Italian Study
- PEARs: Pharmacogenomic Evaluation of Antihypertensive Responses
- ACCG: Antihypertensive Current Care Guideline
- TAIM: Trial of Antihypertensive Interventions and Management
- MADAM: Moexipril as Antihypertensive Drug after Menopause
- VALUE: Valsartan Antihypertensive Longterm Use Evaluation
- AAAA: Antihypertensive and Anti-Anginal Agent
- ATACH: Antihypertensive Treatment of Acute Cerebral Haemorrhage
- ATACH: Antihypertensive Treatment in Acute Cerebral Hemorrhage
- ATACH: Antihypertensive Treatment of Acute Cerebral Hemorrhage
- PATS: Post-stroke Antihypertensive Treatment Study
- SADD: Study of Antihypertensive Drugs and Depressive
- TAIM: Trial of Antihypertensive Intervention and Management
- VALUE: Valsartan Antihypertensive Long-Term Use Eval
- INDANA: Individual Data Analysis of Antihypertensive Intervention Trials
- COTAIM: Continuation of Trial of Antihypertensive Interventions and Management
- COTAIM: Continuation of the Trial of Antihypertensive Intervention Management
- COTAIM: Continuation of Trial Antihypertensive Interventions and Management
- CAIPE: Complex Antihypertensive Intervention Program in the Elderly
- VALUE: Valsartan Antihypertensive Long-term Use Evaluation
- ALLHAT: Antihypertensive Lipid Lowering Heart Attack Trial
- ALLHAT: antihypertensive and lipid-lowering treatment to prevent heart attack trial
- RANKL/ODF: receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor
- TRAF6: Tumor-necrosis-factor receptor-associated factor 6
- TRAF6: Tumor necrosis factor receptor-associated factor 6
- NGF/TNF: nerve growth factor/tumor necrosis factor
- TRAF3: tumor necrosis factor receptor-associated factor 3
- TRAF2: tumor necrosis factor receptor-associated factor 2
- TRAF6: tumour necrosis factor receptor-associated factor 6
- SHOW MORE